12
Total investments
0
Early stage
4
Mid stage
5
Late stage
14y
Years active
Portfolio
9 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2021
Our mission is to build the world’s best home buying and selling experience.
Whether you are buying, selling, or both, our team of industry experts and local agents will provide you with the education, guidance and technology you need, all in one place.
Wherever you are in your real estate journey, our approach to homebuying helps buyers search with confidence, decide with certainty, and negotiate with clarity. Combined with our innovative financial products, Flyhomes Cash Offer and Buy Before You Sell program, we make it easy to move in and move on.
Home lending products offered by Flyhomes Mortgage, LLC NMLS #1733272 | NMLS Consumer Access (https://www.nmlsconsumeraccess.org/)
Board Member
Apr 2021
Cherre is the leader in real estate data and insight. We connect decision makers to accurate property and market information, and help them make faster, smarter decisions. By providing a unique “single source of truth,” Cherre empowers customers to evaluate opportunities and trends faster and more accurately, while saving millions of dollars in manual data collection and analytics costs.
Investor
Oct 2020
Buoy is a Boston-based digital health company that uses AI technology to provide personalized clinical support the moment an individual has a health concern. Developed out of the Harvard Innovation Labs by a team of doctors and data scientists, Buoy navigates people through the healthcare system intelligently, delivering triage at scale, and connecting them with the right care endpoints at the right time based on self-reported symptoms.
Investor
May 2020
Nurx is part of the Thirty Madison family of brands, visit the Thirty Madison homepage for more.
Board Observer
Sep 2019
Delos brings together the best innovations in technology, health, design and science to improve human health in the built environment.
As the pioneer of Wellness Real Estate™, Delos is transforming our homes, offices, schools and other indoor environments by placing health and wellness at the center of design and construction decisions. Delos helps create spaces that actively contribute to human health, performance and well-being by marrying the best innovations in technology, health, science and real estate. The Delos platform includes programming, consulting, research and an array of innovative products and technologies that research suggests may improve occupant well-being.
Investor
Jul 2019
A leading provider of virtual mental health care, Talkspace provides convenient access to high-quality, evidence-based therapy, psychiatry, and self-guided support. The Talkspace network of 5,000+ licensed clinicians includes therapists and psychiatric providers with specialized knowledge of more than 150 conditions and treatment approaches. Founded in 2012, Talkspace pioneered message-based therapy, fulfilling an unmet desire of many people to text with a therapist, any time, from anywhere. We have grown into a single destination for comprehensive mental health care, including specialized therapy for individuals, couples, and teens, psychiatry and medication management, and self-guided tools and resources. All care is delivered through our fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. More than 130 million people have access to Talkspace through their health plans for the cost of a copay or free through their employer, college or university, school district, or government agency. Making high-quality mental health support available to all is the Talkspace mission, and we’re just getting started.
Investor
Jan 2019
Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. Pear’s product, reSET®, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O®, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear’s third product, Somryst® for the treatment of chronic insomnia, was the first PDT submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program. For more information, visit Pear at www.peartherapeutics.com.
Investor
Aug 2015
Trustbridge is a growth-oriented private equity firm with offices in Shanghai, Hong Kong, and Boston. The firm invests globally in innovative, high quality growth opportunities in various stages across Technology, Healthcare and Media. Founded and managed by entrepreneurs and operators, Trustbridge provides patient, long-term capital and partners with management teams building products and services that improve lives globally. Utilizing a growing, global portfolio and deep operational expertise, the firm has a particular focus on helping its portfolio companies enter new international markets, including China.
Trustbridge Partners is committed to investing in and building the best-in-class technology-enabled ecosystems in China, focusing on the needs of China‘s rising middle-class, particularly those with growing sensitivity toward time efficiency, quality of life, and service quality. Our focused verticals are best-in-class technology-enabled healthcare services, space-service communities and educational content services. Our core assets include Carebridge healthcare service delivery platform, WeWork co-working space-as-a-service platform, Douban virtual online communities for the intellectually curious minds, and Trustbridge Global Media for the development and distribution of high-quality children‘s educational content. We believe our focused verticals and core asset holdings enable us to meet an acute deficit in quality supply of best-in-class healthcare, children’s content, community service both online and offline for China‘s rising middle-class, enriching their lives and allowing them to flourish.
We have a young and professional team who are open-minded, empathetic and passionate about our common mission. We invite ambitious, capable and like-minded talents who share our vision, philosophy and culture to join our mission.
Experience · 14 entries
All (14)
Investments (12)
Founder (1)
Board (3)
2021
Investor
Jun 2021
Our mission is to build the world’s best home buying and selling experience.
Whether you are buying, selling, or both, our team of industry experts and local agents will provide you with the education, guidance and technology you need, all in one place.
Wherever you are in your real estate journey, our approach to homebuying helps buyers search with confidence, decide with certainty, and negotiate with clarity. Combined with our innovative financial products, Flyhomes Cash Offer and Buy Before You Sell program, we make it easy to move in and move on.
Home lending products offered by Flyhomes Mortgage, LLC NMLS #1733272 | NMLS Consumer Access (https://www.nmlsconsumeraccess.org/)
Investor
May 2021
Formed in 2010, Terviva is a food and agriculture company that delivers tasty and nourishing plant-based food ingredients from the pongamia tree. We provide patented high-yielding trees and offer proprietary bean processing to create the worlds most sustainable oil and protein food ingredients. Pongamia trees restore farmland to productive use, helping farmers feed people while taking care of the planet.
Learn more at www.Terviva.com.
Board Member
Apr 2021
Cherre is the leader in real estate data and insight. We connect decision makers to accurate property and market information, and help them make faster, smarter decisions. By providing a unique “single source of truth,” Cherre empowers customers to evaluate opportunities and trends faster and more accurately, while saving millions of dollars in manual data collection and analytics costs.
2020
Investor
Oct 2020
Buoy is a Boston-based digital health company that uses AI technology to provide personalized clinical support the moment an individual has a health concern. Developed out of the Harvard Innovation Labs by a team of doctors and data scientists, Buoy navigates people through the healthcare system intelligently, delivering triage at scale, and connecting them with the right care endpoints at the right time based on self-reported symptoms.
Show all 14 entries ↓
Investment activity
2012–2021 · 12 investments
Recent (last 2 years)Earlier
